Member Info for PJT12

Good move, Tomphys. Best not to discuss other shares as it can draw unwanted fire from their holders. Keep calm and keep our heads down is best.

Not that there is any need to do so at present but I cannot help but feel that the SP here would still rise in the event of any fundraising, especially after FDA approval. Two reasons: The massive market potential and the relatively low number of available shares in issue.

Miavoce, many thanks. Imagine the reaction when the idea was first suggested. It just seems overly simple, although clearly not.

Are the cartridges used to capture the live cancer cells the same design for all types of cancers or are they engineered differently to suit each type?

Gawdhelpus, in fairness it was stated in the RNS on Thu, 4th Mar 2021. A couple of weeks slippage was always possible though and, as stated last night, they are on the verge of supplying the AIR.

Fair points in your latest post, golferboy, you clearly are not deramping and have a genuinely held view. My apologies.

Okay, I not going to argue. We obviously just viewed it through different perspectives. All I'll say to prospective investors is to watch last night's presentation:

https://www.youtube.com/watch?v=H51LE6jEJ5c&t=4053s

Agree, it may "drift" on occasions but to have any fear of that is the sort of short-termism that the MMs and others love and play on. It is nothing to do with the company's lack of strength.

Golferboy, rightly or wrongly, my impression of your post after the strength of the performance I saw last night prompts me to think that you are subtley attempting to deramp? Sorry, but that's the way it comes across and I do not say that as some blinkered idiot who is blindly following a share, like many on AIM do.

Another highly pleasing aspect of last night's presentation came in response to the questioner who asked about our prospects in the event of an unsuccessful FDA bid? AN outlined how success is obviously preferred but several other major commercial channels would still leave us highly profitable but "THAT SAID, when we do get FDA
approval .........". He is obviously confident in the product and the FDA's knowledge of it through the years spent building the relationship and understanding it. Read between the lines!

Golferboy, it may be a "long wait" for some stereotypical AIM holders but rest assured, there will be plenty willing to snap-up the quality and huge potential here through any short-sighted impatience on the part of those individuals.

As for "early May"? What is likely to have moved to "late May" or slightly earlier is not a problem for me. Believe me, that is nothing when compared to other shareholders elsewhere who've seen their CEO's 'over enthusiastic' pronouncements slipping by months or even the best part of a year. Our subsequent interims simply said "May" and I am more than happy to see them employing thoroughness rather than rushing things.

(CFO) "We've been positioning / are lining things up (for a NASDAQ listing) when the time is right". No fixed timeline at present.

Brilliant, confident and bursting with enthusiasm. "We are very close to completing the FDA AIR work".

I actually felt very proud listening to Andrew. This is a great story.

Cheers, Miavoce, that's what I was after. This really is an excellent board. Thanks to all who make it so.

I think the point was that AGL were discussing talking to the FDA as far back as the 2016 interims. The relationship between the two has been ongoing for years. 1. You can construe that in two ways: The FDA has presented more barriers than might have been expected to date. 2. Having worked so closely together, the fact that only now - after all this time - is AGL confident enough to submit their application should fill us with confidence. Or, in short, why's it taken so long to reach this stage, in the opinion of the more knowledgeable on here?

I read elsewhere that "the FDA must be running out of excuses" to decline a license for Parsortix. That struck me as rather harsh because from what I can see the FDA has been working with AGL over the years in order to reduce potential hurdles once the submission was made. Any thoughts?

Later today - register here

http://www.proactiveinvestors.co.uk/register/event_details/337

I can't access The Telegraph but Goyathlay posted the following on ADVFN. Primarily about Illumina but there are references to AGL apparently.

www.telegraph.co.uk/investing/shares/questor-illumina-cracked-covid-code-tracks-variants-not-buy/

jackester, do you mind if we get back to you on that at 0700 tomorrow? :-)

......and if you said TIME in today's 'missing word' competition - as in, "take your time" - then give yourself a pat on the back :-)

The perspective through which I'm viewing the resubmission is, they said "May" and it's reassuring to think of the AGL scientific staff meticulously working away in the background to ensure they don't drop the ball at this final hurdle. Take your and do it right.